Josh Maher
All posts from Josh Maher
Josh Maher in Josh's value investing,

Lots of room for Celgene

Celgene (which makes up 1.7% of the Nasdaq 100) has a chart not too far off from the GILD chart we showed WaveBOOM members this week. The stochs are diverging against higher highs in price, as the weekly stochs (not shown) just crossed down. 140 is initial support, followed by 110, which is very strong.